PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
May 16, 2024
PYC Therapeutics Ltd
Cash from Investing Activities
|
PYC Therapeutics Ltd
Cash from Investing Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash from Investing Activities
-AU$627.2k
|
CAGR 3-Years
70%
|
CAGR 5-Years
-379%
|
CAGR 10-Years
-7%
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Investing Activities
-AU$82.7k
|
CAGR 3-Years
-109%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Investing Activities
-$45k
|
CAGR 3-Years
75%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Investing Activities
-$1.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Investing Activities
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
40%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Investing Activities
-AU$25.5m
|
CAGR 3-Years
-186%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Cash from Investing Activities?
Cash from Investing Activities
-627.2k
AUD
-627.2k
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Cash from Investing Activities amounts to -627.2k AUD.
What is PYC Therapeutics Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-7%
-7%
The average annual Cash from Investing Activities growth rates for PYC Therapeutics Ltd have been 70% over the past three years , -379% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
